Table 3.
Descriptive statistics for the DermaSat scales and overall score
| N | % cases | |||||||
|---|---|---|---|---|---|---|---|---|
| Valid | Missing | Mean | SD | Min | Max | Lower cat | Upper cat | |
| Treatment effectiveness (TE) | 213 | 0 | 49.69 | 26.38 | 0 | 100 | 4.7 | 5.2 |
| Convenience of use (CU) | 213 | 0 | 63.85 | 21.35 | 0 | 100 | 1.4 | 12.2 |
| Impact on activities of daily living (ID) | 211 | 2 | 49.16 | 26.85 | 0 | 100 | 8.9 | 6.1 |
| Medical care (MC) | 213 | 0 | 64.50 | 27.51 | 0 | 100 | 2.8 | 23.9 |
| Undesirable side-effects (UE) | 212 | 1 | 74.32 | 27.72 | 0 | 100 | 3.8 | 39.4 |
| General satisfaction (GS) | 211 | 2 | 48.92 | 26.10 | 0 | 100 | 8.5 | 3.8 |
| Overall score | 213 | 0 | 58.10 | 18.16 | 12.5 | 100 | 0.5 | 1.4 |
SD = Standard Deviation, Min = Minimum, Max = Maximum, Lower cat =% of cases in lower response category, Upper cat = % of cases in upper response category.